PATENT CLAIM ANALYSIS

Application Number: 15755618
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "048000"]

Abstract:
Provided are a new crystal form of fludarabine phosphate, a preparation method therefor, a pharmaceutical composition containing same, and an application thereof in preparing medicine. Crystal forms I and II of the fludarabine phosphate have excellent properties in terms of solubleness, dissolution rate, chemical stability, and processing adaptability.

Claim (Index 1):
A crystal form I of 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine-5\u2032-phosphate, wherein the X-ray powder diffraction pattern thereof has characteristic peaks at 2\u03b8 (\u00b0) values of 9.1\u00b10.2, 17.3\u00b10.2, 18.1\u00b10.2, 20.4\u00b10.2, 23.0\u00b10.2, 28.1\u00b10.2.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15760090', '15762895', '15328795', '15123378', '16098103']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7919913123246513
- 35 USC 102 Novelty (BERT): 0.4908241092317113
- Combined Prediction Score: 0.7618745920153572
- Mean Citation Score: 231.988772
- Max Citation Score: 248.48439
- Similarity Product: 207.2177618139696

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test